HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Judy H Chen Selected Research

C-Mel

9/2003Improved yield and stability of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation, by protein engineering.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Judy H Chen Research Topics

Disease

2Neoplasms (Cancer)
09/2003 - 07/2002
1Hodgkin Disease (Hodgkin's Disease)
07/2002

Drug/Important Bio-Agent (IBA)

1Single-Chain AntibodiesIBA
09/2003
1Antineoplastic Agents (Antineoplastics)IBA
09/2003
1beta-Lactamases (beta-Lactamase)IBA
09/2003
1ProdrugsIBA
09/2003
1C-MelIBA
09/2003
1AntigensIBA
09/2003
1Monoclonal AntibodiesIBA
07/2002
1SGN-30 monoclonal antibodyIBA
07/2002

Therapy/Procedure

1Therapeutics
07/2002